Evidence map›Paper›PMID 29153484›Full record

ReviewCurrent opinion in genetics & development2018

Translation initiation factors and their relevance in cancer.

Columba de la Parra, Beth A Walters, Phillip Geter, Robert J Schneider

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in genetics & development, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Computational inference of eIF4F complex function and structure in human cancers.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. DietaryAquaculture nutrition · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Columba de la ParraDepartment of Microbiology and Perlmutter Cancer Center, NYU School of Medicine, New York, NY 10016, USA.
Beth A WaltersDepartment of Microbiology and Perlmutter Cancer Center, NYU School of Medicine, New York, NY 10016, USA.
Phillip GeterDepartment of Microbiology and Perlmutter Cancer Center, NYU School of Medicine, New York, NY 10016, USA.
Robert J SchneiderDepartment of Microbiology and Perlmutter Cancer Center, NYU School of Medicine, New York, NY 10016, USA. Electronic address: robert.schneider@nyumc.org.
NYU Langone’s Laura and Isaac Perlmutter Cancer Center

Funding

Institutional Clinical and Translational Science AwardUL1TR000038 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL · 2012 to 2014
$16.8M
TRAINING PROGRAM IN MOLECULAR ONCOLOGY &IMMUNOLOGYT32CA009161 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARROLL, WILLIAM L., LEVY, DAVID E · 1985 to 2020
$13.3M
Training in Pharmacological SciencesT32GM066704 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BACH, ERIKA A · 2004 to 2018
$2.6M
the mTOR translational control pathway in tamoxifen resistant ER+ breast cancerR01CA207893 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SCHNEIDER, ROBERT JAY · 2017 to 2021
$2.1M
Translational regulation of the breast cancer stem cell by eIF4G1R01CA178509 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SCHNEIDER, ROBERT JAY · 2015 to 2019
$2.0M
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR000038NCI NIH HHS R01 CA178509NCI NIH HHS R01 CA207893NCI NIH HHS T32 CA009161NIGMS NIH HHS T32 GM066704
6 · The paper itself

Abstract

Deregulation of several translation initiation factors occurs in numerous types of cancers. Translation initiation factors are not merely ancillary players in cancer development and progression, but rather, they are key participants in cellular transformation and tumor development. In fact, the altered expression of translation initiation factors is involved in cancer cell survival, metastasis and tumor angiogenesis. Although the exact mechanisms remain to be fully characterized, translation initiation factors comprise novel targets for pharmacologic intervention. Here we review the most recently established roles of initiation factors in cancer development and progression, as well as unique methods used to study translational regulation.

Indexed as

AnimalsCarcinogenesisCell Transformation, NeoplasticGene Expression Regulation, NeoplasticHumansNeoplasmsPeptide Initiation FactorsPeptide Initiation Factors

Identifiers

PMID29153484
PMCPMC7269109
OpenAlexW2770320742

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.